InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,213.70
(
0.50%
)
US TECH 100
17,632.00
(
0.17%
)
Dow Jones
39,389.16
(
0.85%
)
Brent Oil
84.01
(
0.53%
)
Bitcoin
62,413.11
(
2.00%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mentalist

Send PM Follow Ignore
Followers 0
Posts 425
Boards Moderated 0
Alias Born 04/16/2010

mentalist

Re: None

Tuesday, 04/11/2017 7:30:58 AM

Tuesday, April 11, 2017 7:30:58 AM

Post# of 23979
ITEK Completes Patient Recruitment in Phase 2 Trial of a Fixed-dose Combinatio. Top-line data from the FDC study are expected in July.

$2.71 book
Float 18.65
126 million Total cash

Solid catalyst trade, one to keep a eye on

This is a out line nothing more, DD must be done.

Take note they failed Trials in Dec 2016
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up